
Results
11
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
11 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩391,000.00
7D
-4.2%
1Y
-40.1%
ST PharmLtd
Market Cap: ₩2.1t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩99,300.00
7D
-7.2%
1Y
11.1%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,100.00
7D
-1.8%
1Y
15.6%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩118,300.00
7D
-5.2%
1Y
-10.4%
Boryung
Market Cap: ₩759.5b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩8,990.00
7D
-2.2%
1Y
9.5%
JW Holdings
Market Cap: ₩275.0b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,975.00
7D
-4.9%
1Y
20.6%
Chong Kun Dang Holdings
Market Cap: ₩184.7b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩38,800.00
7D
-4.2%
1Y
-17.4%
Ilyang PharmaceuticalLtd
Market Cap: ₩149.9b
Operates as a pharmaceutical company primarily in South Korea.
A007570
₩8,360.00
7D
-5.0%
1Y
-33.6%
Sinsin Pharmaceutical
Market Cap: ₩67.6b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,455.00
7D
-0.7%
1Y
-19.6%
RP Bio
Market Cap: ₩52.7b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩6,080.00
7D
-5.1%
1Y
-5.7%
Korean Drug
Market Cap: ₩36.7b
Manufactures and sells medicines for treating various diseases in South Korea.
A014570
₩3,365.00
7D
-3.9%
1Y
-27.6%